Journal of Nanobiotechnology (Oct 2024)

NIR-II light based combinatorial management of hypertrophic scar by inducing autophagy in fibroblasts

  • Yunxian Dong,
  • Haibin Wang,
  • Youliang Zhang,
  • Yanqun Wu,
  • Ling Lu,
  • Hao Yu,
  • Lingcong Zhou,
  • Peng Zhao,
  • Sixue Ouyang,
  • Zibin Song,
  • Zhicheng Hu,
  • Dongming Lv,
  • Yanchao Rong,
  • Zirui Zhao,
  • Jia Tao,
  • Bing Tang,
  • Shengkang Luo

DOI
https://doi.org/10.1186/s12951-024-02876-9
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 18

Abstract

Read online

Abstract The hypertrophic scar (HS) is a prevalent cutaneous fibrotic disorder that impacts both the aesthetic and functional aspects of the skin, there is an urgent need for a highly safe and effective approach to address the challenge of HS with thick and deep types. Inspired by the superior deep tissue penetrative ability of near-infrared-II (NIR-II) light and potential mitochondria ROS inducing effect of Chinese medicine lycorine (LYC), we fabricated a Cu2Se@LYC (CL) composite by encapsulating LYC on polyvinyl pyrrolidone (PVP) modified Cu2Se nanoparticles. After NIR-II irradiation, CL could induce the generation of reactive oxygen species (ROS) and mitochondrial damage in hypertrophic scar fibroblasts (HSFs). The subsequent release of cytochrome C (cyt-c) from mitochondria into the cytoplasm and upregulation of beclin1 leads to the activation of endogenous apoptosis and autophagy-mediated cell death. The CL + NIR-II treatment exhibited a pronounced anti-scarring effect in both in vitro and in vivo rabbit ear scar models, leading to a significant reduction in the fibrotic markers including Collagen I/III and α-smooth muscle actin (α-SMA). This study comprehensively investigated the crucial role of HSFs’ autophagy in scar management and proposed a safe and effective therapy based on NIR-II laser for clinical application.

Keywords